Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 51
Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment
Yayuan Deng, Mengjia Shi, Yi Lin, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37060-e37060
Open Access | Times Cited: 26
Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
Tianhang Li, Tianyao Liu, Wenjie Zhu, et al.
Clinical Medicine Insights Oncology (2021) Vol. 15
Open Access | Times Cited: 68
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 601-636
Open Access | Times Cited: 11
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 11
Resistance mechanisms to immune checkpoint inhibitors: updated insights
Besan H. Al-Saafeen, Bassam R. Ali, Eyad Elkord
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Nanotopographical 3D-Printed Poly(ε-caprolactone) Scaffolds Enhance Proliferation and Osteogenic Differentiation of Urine-Derived Stem Cells for Bone Regeneration
Fei Xing, Hua‐Mo Yin, Man Zhe, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1437-1437
Open Access | Times Cited: 21
The epigenetic hallmarks of immune cells in cancer
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Myeloid-derived suppressor cell: A crucial player in autoimmune diseases
Dandan Xu, Cheng Li, Yushan Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Connections between Metabolism and Epigenetic Modification in MDSCs
Haiyan Dai, Huaxi Xu, Shengjun Wang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7356-7356
Open Access | Times Cited: 18
Lipid Metabolism and Immune Checkpoints
Qianjin Liao, Yujuan Zhou, Longzheng Xia, et al.
Advances in experimental medicine and biology (2021), pp. 191-211
Closed Access | Times Cited: 14
miR-2337 induces TGF-β1 production in granulosa cells by acting as an endogenous small activating RNA
Lingfang Wang, Xing Du, Qiqi Li, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 12
Epigenetic modifications in the accumulation and function of myeloid-derived suppressor cells
Liangjie Xu, Cuicui Zhou, Yi Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
Lijuan Xu, Fengsen Li, Min Jiang, et al.
International Journal of COPD (2023) Vol. Volume 18, pp. 139-153
Open Access | Times Cited: 4
RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis
Reem Saleh, Varun Sasidharan Nair, Mahmood Al‐Dhaheri, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 9
Differential gene expression of tumor-infiltrating CD4 + T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis
Varun Sasidharan Nair, Reem Saleh, Rowaida Z. Taha, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Chitosan Nanoparticles Loaded with TGF-β1 Inhibit Cervical Cancer Cell Progression Through Down-Regulation of MicroRNA-155 and Activation of Tim-3 Pathway
Meiling Yan, Yali Zhang, Shanshan Chang
Journal of Biomedical Nanotechnology (2021) Vol. 17, Iss. 9, pp. 1850-1857
Closed Access | Times Cited: 6
Transcriptomic Profiling of Circulating HLA-DR– Myeloid Cells, Compared with HLA-DR+ Myeloid Antigen-presenting Cells
Reem Saleh, Rowaida Z. Taha, Varun Sasidharan Nair, et al.
Immunological Investigations (2020) Vol. 50, Iss. 8, pp. 952-963
Open Access | Times Cited: 5
A core of differentially methylated CpG loci in gMDSCs isolated from neonatal and adult sources
Isabella Berglund-Brown, Emily Nissen, Devin C. Koestler, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer
Reem Saleh, Varun Sasidharan Nair, Khaled Murshed, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 9, pp. 2625-2638
Closed Access | Times Cited: 4
Page 1

Scroll to top